金城医药

- 300233

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
金城医药(300233) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入72,191.92337,338.74251,531.84175,857.8393,169.66
营业收入72,191.92337,338.74251,531.84175,857.8393,169.66
二、营业总成本68,209.12310,316.41233,320.64160,445.0582,459.80
营业成本47,520.54201,959.94150,587.77104,427.3551,710.40
营业税金及附加925.063,927.052,927.262,019.841,041.89
销售费用7,479.4949,638.7138,954.7927,804.9217,186.22
管理费用9,017.2137,846.2128,439.3318,234.558,803.94
财务费用-15.58-89.88155.80-199.64-54.16
研发费用3,282.4017,034.3712,255.698,158.023,771.51
资产减值损失----------
公允价值变动收益-0.078.65-30.5146.4420.31
投资收益81.79-166.51-152.43-217.16-16.43
其中:对联营企业和合营企业的投资收益41.42-40.26-41.12-48.14-31.57
汇兑收益----------
三、营业利润5,009.2826,713.8219,526.6416,277.1311,564.96
加:营业外收入3.88384.65217.54155.437.19
减:营业外支出33.16253.6650.0232.5816.67
其中:非流动资产处置损失----------
四、利润总额4,980.0026,844.8019,694.1616,399.9811,555.48
减:所得税费用1,350.116,071.273,484.082,503.742,639.58
五、净利润3,629.8920,773.5316,210.0813,896.258,915.89
归属于母公司所有者的净利润3,505.4819,678.0815,105.3813,059.168,297.13
少数股东损益124.411,095.461,104.70837.09618.76
六、每股收益
基本每股收益(元/股)0.09000.52000.40000.34000.2200
稀释每股收益(元/股)0.09000.52000.40000.34000.2200
七、其他综合收益--2,326.86------
八、综合收益总额3,629.8923,100.3916,210.0813,896.258,915.89
归属于母公司所有者的综合收益总额3,505.4822,004.9315,105.3813,059.168,297.13
归属于少数股东的综合收益总额124.411,095.461,104.70837.09618.76
下载全部历史数据到excel中 返回页顶